Skip to main content
Scars, Burns & Healing logoLink to Scars, Burns & Healing
. 2020 Jun 30;6:2059513120924749. doi: 10.1177/2059513120924749

Management of necrotising fasciitis within a burns centre: do outcomes differ?

Joseph A Ward 1,, John A G Gibson 2, Dai Q Nguyen 2
PMCID: PMC7328481  PMID: 32655900

Abstract

Introduction:

Many similarities exist between the care of necrotising fasciitis (NF) and burn injury patients. Each group represents a small but complex cohort requiring multiple theatre trips, specialist reconstruction, meticulous wound care and multidisciplinary management. Over a six-year period, we sought to examine the clinical outcomes of NF patients managed within a burns centre against those managed by a plastic surgery service.

Methods:

A retrospective case-note review was performed for all identifiable patients referred to our institution’s designated burns centre or plastic surgery service between 2008–2014. Patient characteristics, length of stay, wound-related and clinical outcomes were extracted and descriptively presented with statistical analysis performed for survival and length of stay.

Results:

Twenty-nine patients were included in the study (burns centre [B]: 17 patients; plastic surgery service [P]: 12 patients). Median total length of stay (B: 37 vs. P: 50 days, P=0.38), local length of stay (27 vs. 19 days, P=0.29) and survival till discharge (94.4% vs. 100%, P=0.73) demonstrated no statistically significant difference.

Conclusion:

Caring for NF patients within a burns centre facilitated easier access to specialist reconstructive expertise and multidisciplinary care but did not lead to statistically significant differences in length of stay or survival. The management of NF within a burns centre facilitated provision of high-quality care to a highly challenging patient group.

Keywords: Necrotising fasciitis, burns centre management, clinical outcomes

Lay Summary

graphic file with name 10.1177_2059513120924749-img1.jpg

graphic file with name 10.1177_2059513120924749-img2.jpg

graphic file with name 10.1177_2059513120924749-img3.jpg

Research background:

Looking after patients with flesh-destroying infections (necrotising fasciitis [NF]) and burns frequently require very similar expertise and clinical resources. A small but increasing number of specialist burns centres will currently accept NF patients for surgical reconstruction and rehabilitation.

Question being asked:

Does performing the surgical reconstruction and rehabilitation of NF patients in burns centres improve patient survival and reduce hospital stay?

How work was conducted:

The medical notes of NF patients referred to our hospital during 2008–2014 were reviewed following a change of practice (acceptance of NF to our burns centre in 2010). The survival, hospital-stay, wound healing and complications of patients managed by our plastic surgery and burns services were compared and statistically analysed.

What we did we learn:

Caring for NF patients in a burns centre improved access to specialist expertise and allowed provision of high-quality care but did not lead to measurable improvements in patient outcome.

Introduction

Necrotising fasciitis (NF) is a rare, severe infection of the skin and subcutaneous tissue that causes rapidly progressive soft-tissue necrosis.1 It most commonly occurs in older, immunocompromised patients suffering from synergistic aerobic and anaerobic infections.2 Population-based studies demonstrate an incidence of 0.15–0.55 cases per 100,000 annually with mortality rates in the range of 8.6%–20.8% within developed healthcare systems.311 Prompt diagnosis, early aggressive surgical debridement and judicious critical care represent the fundamental tenets of management during initial illness.12 Once on the road to recovery, patients conversely necessitate expert reconstruction undertaken within a specialist setting. Holistic support from a multidisciplinary team of nurses, physiotherapists, occupational therapists and psychologists is fundamental to minimising long-term physical and psychological disability.13,14

Many similarities can be drawn between the management of NF patients and patients with large burn injuries including requirements for lengthy periods of intensive care, multiple operating theatre trips and frequent dressing changes. Both groups require multidisciplinary care and pose difficult reconstructive challenges best addressed by surgeons with specialist expertise. Due to the analogous medical and nursing needs of patients with burn injuries and NF, NF patients appropriate for reconstruction have been accepted by our institution’s regional burns centre since April 2010. Before this date, patients ready and suitable for reconstruction were accepted by the regional plastic surgery service. Following the service development, we set out to review the clinical outcomes of each group focusing on length of stay (LOS) and survival to determine whether burn centre management improved clinical outcomes and overall care.

Methods

A retrospective case-note review was performed of all identifiable NF patients referred and accepted to our institution between April 2008 and April 2014. Parameters within the following domains were extracted from each patient’s notes: patient characteristics; LOS; survival; and wound-related and clinical outcomes. Two LOS outcomes were measured: local LOS with our service; and total LOS. Total LOS was defined as the sum of local and referring centre LOS. A more detailed break-down of parameters extracted is shown in Figure 1.

Figure 1.

Figure 1.

Data extracted from the case-note review.

Due to the small sample size of each cohort, a descriptive statistical approach was taken with only the primary and secondary null hypotheses tested. Our primary null hypothesis was that there was no difference in survival between patients managed at the burns centre and those managed by the regional plastic surgery service. The secondary null hypothesis was that there was no difference in total or local LOS between the groups. To test the null hypotheses, we employed the Chi-squared and unpaired T-test with an α-value < 0.05 taken as statistically significant.

Results

Twenty-nine NF patients were included in the study, comprising 12 patients managed by the plastic surgery service (P) before April 2010 and 17 patients managed by the regional burns service (B) after April 2010. The groups were demographically equivalent for age, gender and median percentage total body surface area (% TBSA) tissue loss (B: 4% vs. P: 3%; Figure 2a). Patients were mostly referred from external hospitals (B: 82.3% vs. P: 75%) with no difference in microbiological profile between study groups. The causation and anatomical location of NF between study groups were similar and are presented in Figure 2b and 2c.

Figure 2.

Figure 2.

(a) Cohort characteristics. (b) Aetiology of NF. (c) Location of NF. NF, necrotising fasciitis.

We did not demonstrate any statistically significant difference in survival (B: 94.1% vs. P: 100%; P = 0.73), median local (B: 27 days vs. P: 19 days; P = 0.29) or total LOS (B: 37 days vs. P: 50 days; P = 0.38) between the study groups (Figure 3a and 3b). Median duration referral to transfer, debridement to healing and topical negative pressure therapy as well as number of theatre trips (locally and total), rates of any complication and number of patients discharged directly home are summarised and presented in Figure 3c.

Figure 3.

Figure 3.

(a) Percentage of patients surviving till discharge. (b) Median length of stay (local and total). (c) Other clinical and wound-related outcomes.*

Discussion

NF patients represent a small and complex patient group that, unlike burn patients, do not benefit from systematic and ongoing analysis of outcomes with data collection challenged by the low number of incident cases.15 Despite a reportedly increasing international incidence, we did not observe an increase in the number of cases seen at our hospital with a static mean of 4.6 cases per year across both cohorts.3,1618 The patient demographic in our study matched the profile of NF patients reported in other studies with a preponderance of men and a mean age close to 50 years.9,11,16,1927 The established risks factors of diabetes mellitus, obesity and bacterial virulence were prevalent across our cohort with no significant differences between the groups.2,28,29 Our sample was derived from a mixed rural–urban population and did not demonstrate a bimodal age distribution, in contrast, to the most recent UK metropolitan analysis.9

The most common microbiological pathogens were Group A beta-haemolytic streptococcus followed by mixed aerobic and anaerobic growths (Escherichia coli, Bacteroides fragilis, Enterococcus faecalis) and other non-Group A beta-haemolytic streptococcus species (Lancefield Groups B and C). Bladder and bowel species were well represented, and no difference was seen between the microbiological profile of the burns and plastic surgery groups. Our experience was broadly in line with an alternative UK experience that identified Group A streptococcus, E. coli and Enterococcus species as the most frequent pathogens.9 It has been suggested that managing NF patients within a burns service presents an excellent way for virulent pathogenic organisms to colonise burns centres. Interestingly, at our centre we saw no evidence of this phenomenon demonstrating that attentive infection control encompassing adherence to hand hygiene, MRSA/CPO screening, thorough facility cleans pre- and post-procedure allay the risk of cross-infection. No incidences of pathogenic cross-infection were noted across either cohort.

We found no statistically significant difference in mortality between the study groups with only a single death in the burns centre cohort and no deaths in the plastic surgery cohort. The burns centre mortality rate of 5.5% was lower than the published range of 7.6%–33% (Figure 4) and can be explained by the small sample size and longstanding policy of both services to not accept referrals until critical illness has resolved (although no referrals were ultimately declined during the study period). Such practice is not ubiquitous across burns centres, with some authors suggesting referral and transfer earlier in the clinical course may improve outcomes.20 Nonetheless the stance is justifiable as a specialist service where resources are finite and early recognition with immediate aggressive debridement is the fundamental determinant of outcome.

Figure 4.

Figure 4.

Published studies reporting outcomes for patients with necrotising fasciitis.*

*Greyed-out boxes indicate study reporting burns centre experience.

We found no statistical difference between study groups for total and local LOS, suggesting that burns centre management did not alter LOS. Interestingly, the total LOS for those patients receiving burns centre management was less than the plastic surgery cohort, reflecting the prompter transfer times to our burns centre. The LOS at our local burns centre was comparative to the average LOS for the five other published studies reporting burns centre outcomes (Figure 4) with ranges of 24.4–34.9 days.16,2023 Direct head-to-head comparison against the published literature is challenged by the lack of explicit and standardised outcome reporting for total LOS with comparative studies rarely stating LOS at referring centres. In a single small study of 10 patients over five years, Barillo et al. documented a mean time to burns centre referral of 8.9 days with a mean local LOS of 34.9 days and total LOS of 43.8 days.21

The median duration from referral to transfer was 0.5 days for the burns centre group compared to seven days for the plastic surgery group, reflecting greater availability of beds within the burns service facilitating prompter transfers. Redman et al., in their burn centre experience of 12 patients over five years, reported a mean diagnosis to transfer time of 14 days (range = 1–94 days) with a mean 1.8 (range = 0–6) procedures before transfer and 3.4 (range = 0–10) burns centre procedures.20 For this study, patients underwent an equivalent number of local theatre trips in the burns and plastic surgery groups reflecting the similar surgical approaches taken by services towards patients received at equivalent stages in their wound-healing journeys. The median number of TNPT days for the burns centre group was 17.5 days in 11 patients compared to 20 days in four patients for the plastic surgery group. These findings are similar to those of Endorf et al., who reported an average duration of 16.9 TNPT days in 24 patients managed within a burns centre.16 In all settings, TNPT dressing was employed as a highly versatile temporising measure to facilitate wound bed preparation during patient optimisation prior to definitive closure.

Eleven patients (37.9%; B: 7. P: 4) were identified as having NF of the perineal or genital region (Fournier’s gangrene [FG]) with a precipitant cause identified in the majority of patients. FG patients were managed analogously to other NF patients with judicious debridement and dressing before definitive surgery. Dressing changes (particularly vacuum-assisted closure applications) were challenged by the anatomical morphology of the region with either split thickness skin grafting, local flaps or testes burial in the ipsilateral thigh performed for definitive surgery. Skin grafting procedures were challenged by poor take with all patients experiencing some degree of graft loss, one patient experiencing complete graft loss and three patients requiring revisional grafting. After successful skin grafting, we found FG patients quickly rehabilitated and were promptly discharged. Rates of complication and discharge directly home did not differ between the study groups. Recorded complications were predominantly medical including pulmonary embolism, endocarditis, Clostridium difficile infection and stomal problems. Discharge directly home was achieved for 77% of the burns cohort compared to 83.3% of the non-burns cohort and compares to 54% in the published literature.16 We suggest that discharge directly home is an insufficiently reported surrogate marker for quality of care in NF cohorts (and for burn care more generally). Encompassing survival, it represents a significant milestone in recovery, restored independence and is reflective of the multidisciplinary care provided by nursing and allied health professionals.

No criterion was set for the minimum level of tissue loss accepted with the range of received tissue loss 1%–7% TBSA. All referred ward-based NF patients fit enough to undergo a spinal or general anaesthetic were accepted by burns and plastic surgery. A long-standing protocol to ring-fence at least one burns network bed was enforced throughout the study period. As a burns centre with excess bed capacity and flexible staffing arrangements, we have found that managing NF patients did not impede admissions of emergency burns and increased service utilisation, especially when incident NF admissions were relatively low at a mean 5.2 per year. By only accepting NF patients suitable for ward-level care, we were able to prioritise beds for burns patient (where necessary) with the option to keep NF patients resident at referring centres supported by outreach services when a bed was unavailable. While we appreciate other burns centres may not be so fortunate as to have redundant capacity, we strongly feel admitting NF patients makes organisational and financial logic as well as improving quality of care provided to a unique cohort who would not otherwise benefit.

While there is an increasing incidence of NF in the developed world, there is a contrasting decline in the incidence of severe burns due to improved health and safety measures. This represents a strategic concern for burn services that must demonstrate resource utilisation, retain clinical expertise but also ensure emergency availability of burns beds. The cost of managing NF within and outside of a burns unit has been examined by several authors.23,3032 Faucher et al., in one US burns centre study, reported mean costs of $5202 per day despite cost containment measures.23 Jiménez-Pacheco et al., in a Spanish study conducted by a urology service, reported mean costs of €25,108 ($27,989) per patient admitted to an intensive care unit and requiring at least one debridement.32 Widjaja et al. also costed their Australian experience in 92 sequential patients at a mean of $34,887 per patient but did not include costs incurred by referring hospitals or during rehabilitation.30 To inform and contextualise our analysis of clinical outcomes, we undertook a cost assessment that demonstrated median ward-based costs, theatre costs and total costs (B: $20,560 [£16,606] vs P: $9644 [£7789]; P = 0.06) were greater within the burns centre compared to the plastic surgery groups but the analysis did not reach statistical significance.

Surprisingly, despite the increasing prevalence and greater costs of NF care being undertaken within burns services, there is no UK clarity amongst commissioning bodies (local clinical commissioning groups or specialised services commissioners) over who is responsible for funding NF care. This causes regional differences between services for the acceptance of NF patients dependent on local funding arrangements. Due to the Welsh burns service being commissioned on a non-tariff basis, management of NF cases within our burns centre is economic. NHS commissioners would be well-placed to address variation in commissioning for NF care amongst burns and plastic surgery services so that such care is appropriately and equitably funded while not financially detracting from core burn activities.

This paper has three main weaknesses. First, it is a retrospective study with data collection dependent on the availability and quality of pre-existing clinical documentation, especially for wound-related outcomes. This increases risk of outcome reporting bias while also representing a methodological flaw, albeit one inherent to all other studies identified in our literature review. Second, the infrequent incidence of NF limits the sample size across the six-year study period and increases the difficulty of detecting statistically significant differences between burn centre and non-burn centre cohorts. Third, the burn centre and plastic surgery groups are not contemporaneous and are derived from different time periods; therefore, incremental technological or procedural developments across this period could account for some differences in clinical outcome. Methodologically, we specifically chose not to include the Laboratory Risk Indicator for Necrotising Fasciitis score in our comparative analysis because it is a physiological score for improving early diagnosis of NF and not an outcome prediction tool. Furthermore, the reported sensitivity (68%–80%) of the score has been questioned and the necessary information was not always available during our retrospective notes review.33

Conclusion

We have compared survival and LOS as well as other clinical and wound-related outcomes for NF patients managed within a burns centre and plastic surgery service at the same institution over a period of six years. Managing NF patients within a burns centre did not translate into measurable and statistically significant improvements in survival, LOS or other clinical outcomes. Nevertheless, the incremental gains of high-quality supportive care, judicious wound management, timely reconstruction and a well set up burns multidisciplinary team cumulatively provided the best opportunity for healing and recovery following NF. These subtler unmeasured gains were brought about through greater access to a specialist multidisciplinary team focused primarily on physical wound healing and psychosocial rehabilitation than would have possible under a pure plastic surgery service. In an era where the clinical outcomes for NF patients have not altered despite improvements in critical care and early aggressive surgical debridement, we would encourage all clinicians managing NF patients to explore the management of NF within a burns centre.

Acknowledgments

This study has been registered as a service evaluation with the Clinical Audit and Effectiveness Department of Swansea University Health Board (Project ID: 19/20/75)

Footnotes

Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding: The author(s) received no financial support for the research, authorship, and/or publication of this article.

References

  • 1. Elliott D, Kufera JA, Myers RA. The microbiology of necrotizing soft tissue infections. Am J Surg 2000; 179(5): 361–366. [DOI] [PubMed] [Google Scholar]
  • 2. Francis KR, Lamaute HR, Davis JM, et al. Implications of risk factors in necrotizing fasciitis. Am Surg 1993; 59(5): 304–308. [PubMed] [Google Scholar]
  • 3. Kaul R, McGeer A, Low DE, et al. Population-based surveillance for group A streptococcal necrotizing fasciitis: Clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario Group A Streptococcal Study. Am J Med 1997; 103(1): 18–24. [DOI] [PubMed] [Google Scholar]
  • 4. Fontes RA, Jr, Ogilvie CM, Miclau T. Necrotizing soft-tissue infections. J Am Acad Orthop Surg 2000; 8(3): 151–158. [DOI] [PubMed] [Google Scholar]
  • 5. Tsitsilonis S, Druschel C, Wichlas F, et al. Necrotizing fasciitis: is the bacterial spectrum changing? Langenbecks Arch Surg 2013; 398(1): 153–159. [DOI] [PubMed] [Google Scholar]
  • 6. Das DK, Baker MG, Venugopal K. Risk factors, microbiological findings and outcomes of necrotizing fasciitis in New Zealand: a retrospective chart review. BMC Infect Dis 2012; 12: 348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Angoules AG, Kontakis G, Drakoulakis E, et al. Necrotising fasciitis of upper and lower limb: a systematic review. Injury 2007; 38 (Suppl. 5): S19–26. [DOI] [PubMed] [Google Scholar]
  • 8. Khamnuan P, Chongruksut W, Jearwattanakanok K, et al. Necrotizing fasciitis: risk factors of mortality. Risk Manag Healthc Policy 2015; 8: 1–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Glass GE, Sheil F, Ruston JC, et al. Necrotising soft tissue infection in a UK metropolitan population. Ann R Coll Surg Engl 2015; 97(1): 46–51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Anaya DA, McMahon K, Nathens AB, et al. Predictors of mortality and limb loss in necrotizing soft tissue infections. Arch Surg 2005; 140(2): 151–157; discussion 158. [DOI] [PubMed] [Google Scholar]
  • 11. Swain RA, Hatcher JC, Azadian BS, et al. A five-year review of necrotising fasciitis in a tertiary referral unit. Ann R Coll Surg Engl 2013; 95(1): 57–60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. McHenry CR, Piotrowski JJ, Petrinic D, et al. Determinants of mortality for necrotizing soft-tissue infections. Ann Surg 1995; 221(5): 558–563; discussion 563–565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Gully S. Nursing management of necrotising fasciitis. Nurs Stand 2002; 16(52): 39–42. [DOI] [PubMed] [Google Scholar]
  • 14. Rietveld JA, Pilmore HL, Jones PG, et al. Necrotising fasciitis: a single centre’s experience. N Z Med J 1995; 108(995): 72–74. [PubMed] [Google Scholar]
  • 15. Stylianou N, Buchanan I, Dunn K. A review of the international Burn Injury Database (iBID) for England and Wales: descriptive analysis of burn injuries 2003–2011. BMJ Open 2015; 5(2): e006184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Endorf FW, Supple KG, Gamelli RL. The evolving characteristics and care of necrotizing soft-tissue infections. Burns 2005; 31(3): 269–273. [DOI] [PubMed] [Google Scholar]
  • 17. Chelsom J, Halstensen A, Haga T, et al. Necrotising fasciitis due to group A streptococci in western Norway: incidence and clinical features. Lancet 1994; 344(8930): 1111–1115. [DOI] [PubMed] [Google Scholar]
  • 18. Voelker R. Making sense of group A streptococcus scare. JAMA 1994; 272(3): 190–191. [PubMed] [Google Scholar]
  • 19. Hodgins N, Damkat-Thomas L, Shamsian N, et al. Analysis of the increasing prevalence of necrotising fasciitis referrals to a regional plastic surgery unit: a retrospective case series. J Plast Reconstr Aesthet Surg 2015; 68(3): 304–311. [DOI] [PubMed] [Google Scholar]
  • 20. Redman DP, Friedman B, Law E, et al. Experience with necrotizing fasciitis at a burn care center. South Med J 2003; 96(9): 868–870. [DOI] [PubMed] [Google Scholar]
  • 21. Barillo DJ, McManus AT, Cancio LC, et al. Burn center management of necrotizing fasciitis. J Burn Care Rehabil 2003; 24(3): 127–132. [DOI] [PubMed] [Google Scholar]
  • 22. Bernal NP, Latenser BA, Born JM, et al. Trends in 393 necrotizing acute soft tissue infection patients 2000–2008. Burns 2012; 38(2): 252–260. [DOI] [PubMed] [Google Scholar]
  • 23. Faucher LD, Morris SE, Edelman S, et al. Burn center management of necrotizing soft-tissue surgical infections in unburned patients. Am J Surg 2001; 182(6): 563–569. [DOI] [PubMed] [Google Scholar]
  • 24. Proud D, Bruscino Raiola F, Holden D, et al. Are we getting necrotizing soft tissue infections right? A 10-year review. ANZ J Surg 2014; 84(6): 468–472. [DOI] [PubMed] [Google Scholar]
  • 25. Wang JM, Lim HK. Necrotizing fasciitis: eight-year experience and literature review. Braz J Infect Dis 2014; 18(2): 137–143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Tunovic E, Gawaziuk J, Bzura T, et al. Necrotizing fasciitis: a six-year experience. J Burn Care Res 2012; 33(1): 93–100. [DOI] [PubMed] [Google Scholar]
  • 27. Pakula AM, Kapadia R, Freeman B, et al. A 3-year experience with necrotizing fasciitis: favorable outcomes despite operative delays in a busy acute care hospital. Am Surg 2012; 78(10): 1059–1062. [PubMed] [Google Scholar]
  • 28. Goh T, Goh LG, Ang CH, et al. Early diagnosis of necrotizing fasciitis. Br J Surg 2014; 101(1): e119–125. [DOI] [PubMed] [Google Scholar]
  • 29. Hasham S, Matteuci P, Stanley PR, et al. Necrotising fasciitis. BMJ 2005; 330(7495): 830–833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Widjaja AB, Tran A, Cleland H, et al. The hospital costs of treating necrotizing fasciitis. ANZ J Surg 2005; 75(12): 1059–1064. [DOI] [PubMed] [Google Scholar]
  • 31. Mulla ZD, Gibbs SG, Aronoff DM. Correlates of length of stay, cost of care, and mortality among patients hospitalized for necrotizing fasciitis. Epidemiol Infect 2007; 135(5): 868–876. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Jimenez-Pacheco A, Arrabal-Polo MA, Arias-Santiago S, et al. Fournier gangrene: description of 37 cases and analysis of associated health care costs. Actas Dermosifiliogr 2012; 103(1): 29–35. [DOI] [PubMed] [Google Scholar]
  • 33. Burner E, Henderson O, Burke G, et al. Inadequate Sensitivity of Laboratory Risk Indicator to Rule Out Necrotizing Fasciitis in the Emergency Department. West J Emerg Med 2016; 17(3): 333–336. [DOI] [PMC free article] [PubMed] [Google Scholar]

How to cite this article

  1. Ward JA, Gibson JAG, Nguyen DQ. Management of nectorsing fasciitis within a burns centre: do outcomes differ? Scars, Burns & Healing, Volume 6, 2020. DOI: 10.1177/2059513118924749. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Scars, Burns & Healing are provided here courtesy of SAGE Publications

RESOURCES